author-photo

Javier Ros-Montañá

Hebron University

2

Papers

1

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Patient and tumor characteristics as determinants of overall survival (OS) in BRAF V600 mutant (mt) metastatic colorectal cancer (mCRC) treated with doublet or triplet targeted therapy.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The role of ipilimumab after anti-PD-1 treatment: two case reports and a literature review

2019 Melanoma Research
Show All
- Source
- Cite
- Save
Citations (1)